NCPR is supported by:

|
4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
May 17, 2013 | NPR ·
May 17, 2013 | NPR ·
May 17, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
May 19, 2013 | NPR ·
May 19, 2013 | NPR ·
May 19, 2013 | NPR ·
Latest Saturday rundownWE Saturday Feature
May 18, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
May 19, 2013 | NPR ·
cystic fibrosis
Jan 2, 2013 — The success of Kalydeco, a drug to treat cystic fibrosis, has been decades in the making — since the discovery of the gene associated with the disease. The time from gene discovery to successful drug may be shortening, but there are only a handful of drugs like Kalydeco on the market.
Feb 1, 2012 — The Food and Drug Administration approved the first drug that treats cystic fibrosis by addressing an underlying cause of the disease. But the medicine, called Kalydeco, will cost nearly $300,000 a year.
Feb 25, 2011 — On this week's show, we talk about results of a national poll that show confusion about the federal health law, plus health care woes from Tennessee and Pennsylvania. And we bring you two stories of exercise improving the health of seniors — from their muscles to their minds.
Feb 24, 2011 — An experimental medicine, taken twice a day, dramatically improved breathing in people whose cystic fibrosis stems from a particular genetic defect. If approved by the Food and Drug Administration, the medicine could be very pricey.
Comments |


on:




